Coagulation disorders during CRS of a BCMA targeted CAR T cell therapy in relapsed/refractory multiple myeloma: Periodic results of a phase I clinical trial

被引：0
|
作者：
Shao, Mi [1 ]
Hu, Yongxian [1 ]
Xu, Huijun [1 ]
Zhang, Yanlei [1 ]
Cui, Jiazhen [1 ]
Huang, He [1 ]
机构：
[1] Zhejiang Univ, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China
来源：
BONE MARROW TRANSPLANTATION | 2019年 / 54卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
O053
引用
收藏
页码：45 / 46
页数：2
相关论文
共 50 条
  • [21] CRS-related coagulopathy in BCMA targeted CAR-T therapy: a retrospective analysis in a phase I/II clinical trial
    Shao, Mi
    Yu, Qin
    Teng, Xinyi
    Guo, Xin
    Wei, Guoqing
    Xu, Huijun
    Cui, Jiazhen
    Chang, A. H.
    Hu, Yongxian
    Huang, He
    BONE MARROW TRANSPLANTATION, 2021, 56 (07) : 1642 - 1650
  • [22] CRS-related coagulopathy in BCMA targeted CAR-T therapy: a retrospective analysis in a phase I/II clinical trial
    Mi Shao
    Qin Yu
    Xinyi Teng
    Xin Guo
    Guoqing Wei
    Huijun Xu
    Jiazhen Cui
    A. H. Chang
    Yongxian Hu
    He Huang
    Bone Marrow Transplantation, 2021, 56 : 1642 - 1650
  • [23] Radiation therapy as a bridging and salvage strategy in patients with relapsed or refractory multiple myeloma undergoing BCMA-targeted CAR T-cell therapy
    Ababneh, Hazim S.
    Yee, Andrew J.
    Raje, Noopur S.
    Martin, Sidney
    Frigault, Matthew J.
    Ng, Andrea K.
    Patel, Chirayu G.
    RADIOTHERAPY AND ONCOLOGY, 2023, 189
  • [24] Anti-BCMA CAR-T cell immunotherapy for relapsed or refractory multiple myeloma
    Zhang, Xiaohui
    Ouyang, Chenxi
    Sun, Guofeng
    Liu, Hongfeng
    Qi, Junyuan
    Suo, Xiaohui
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2023, 26 (04)
  • [25] Clinical Outcomes and Salvage Therapies in Patients with Relapsed/Refractory Multiple Myeloma Following Progression on BCMA-Targeted CAR-T Therapy
    Reyes, Kevin R.
    Liu, Yen-Chun
    Huang, Chiung-Yu
    Banerjee, Rahul
    Martin, Thomas
    Shah, Nina
    Wong, Sandy W.
    Wolf, Jeffrey L.
    Arora, Shagun
    Chung, Alfred
    BLOOD, 2022, 140
  • [26] CT053, Anti-BCMA CAR T-cell therapy for Relapsed/Refractory Multiple Myeloma: Proof of Concept results from a Phase I Study
    Hao, Siguo
    Jin, Jie
    Yu, Kang
    Li, Zonghai
    Zhang, Wenhao
    Yang, Min
    Jiang, Songfu
    Chen, Peishuai
    Ma, Liyuan
    Meng, Haitao
    He, Mingxia
    Wang, Wei
    Chen, Linjun
    Huang, Xin
    Xing, Chongyun
    Yuan, Daijing
    Tao, Rong
    Wang, Shasha
    Dai, Lihui
    Ma, Hong
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E54 - E55
  • [27] Radiation therapy as bridging and salvage strategy in patients with relapsed or refractory multiple myeloma undergoing BCMA-targeted CAR T-cell therapy
    Ababneh, Hazim
    Yee, Andrew
    Raje, Noopur
    Martin, Sidney
    Frigault, Matthew
    Ng, Andrea
    Patel, Chirayu
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2024, 47 (10): : S31 - S32
  • [28] CAR T-cell therapy for relapsed or refractory multiple myeloma
    Stirrups, Robert
    LANCET ONCOLOGY, 2019, 20 (06): : E297 - E297
  • [29] Clinical responses and pharmacokinetics of fully human BCMA targeting CAR T-cell therapy in relapsed/refractory multiple myeloma.
    Li, Chunrui
    Zhou, Jianfeng
    Wang, Jue
    Hu, Guang
    Du, Aihua
    Zhou, Xiaoxi
    Meng, Li
    Hong, Zhenya
    Chen, Liting
    Mao, Xia
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [30] Prognostic Impact of Clinical Factors and Cell Composition of Apheresis Samples on BCMA CAR-T Cell Therapy for Relapsed or Refractory Multiple Myeloma
    Marumo, Yoshiaki
    Ri, Masaki
    Ebina, Toru
    Nakamura, Tomoyuki
    Sasaki, Hirokazu
    Kinoshita, Shiori
    Narita, Tomoko
    Suzuki, Tomotaka
    Sanda, Takaomi
    Nanri, Takanori
    Komatsu, Hirokazu
    Iida, Shinsuke
    BLOOD, 2024, 144 : 24116 - 24117
12345